Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B44128abd3571215079b0cceacc41ae1e> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B44128abd3571215079b0cceacc41ae1e NCIT_P378 "NCI" @default.
- B44128abd3571215079b0cceacc41ae1e type Axiom @default.
- B44128abd3571215079b0cceacc41ae1e annotatedProperty IAO_0000115 @default.
- B44128abd3571215079b0cceacc41ae1e annotatedSource NCIT_C121538 @default.
- B44128abd3571215079b0cceacc41ae1e annotatedTarget "A human immunoglobulin (Ig) G1 monoclonal antibody directed against the cell surface receptor CD40 with potential immunostimulatory and antineoplastic activities. Upon intratumoral administration, mitazalimab binds to CD40 on antigen-presenting dendritic cells, which leads to the activation and proliferation of effector and memory T-cells, and enhances the immune response against tumor cells. In addition, this agent binds to the CD40 antigen present on the surfaces of tumor cells, which induces antibody-dependent cytotoxicity (ADCC). This eventually inhibits the proliferation of CD40-expressing tumor cells. CD40, a stimulatory receptor and a member of the tumor necrosis factor (TNF) receptor superfamily, is expressed on various immune cells, such as macrophages, dendritic cells and various tumor cell types; it plays a key role in the activation of the immune system." @default.